ArticleCureus2024
Reproductive Health Among School Employees in Vijayapura, Karnataka.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Cervical cancer typically progresses over 10-20 years, making it a preventable disease and underscoring the importance of screening. In low-resource settings, Papanicolaou (Pap) smears and visual inspection with acetic acid (VIA) serve as primary screening tools. This study was conducted as part of the noncommunicable disease camps organized by the government of Karnataka, India. Additionally, it aimed to evaluate the knowledge, attitudes, and practices related to contraception among women of reproductive age. Methods This cross-sectional study was conducted from June to August 2022 in primary health centers, community health centers, and government schools across all the Talukas of Vijayapura District, Karnataka, India. A total of 6,257 women participated in the study. The researchers interviewed all participants, obtained detailed medical histories, and performed pelvic examinations as part of the evaluation. Additionally, they conducted both VIA and Pap smears. Results A total of 6,257 women were sensitized for cervical cancer screening, of whom 5,114 registered, resulting in an acceptance rate of 81.73%. However, 1,143 participants (18.27%) refused screening, with the most common reason being unwillingness to undergo an examination. Only 3,316 women (53.91%) were aware of cervical cancer, and just 1,689 (27.1%) understood that it could be detected at an early stage. The VIA results indicated that 9.1% (n = 865) of the women tested positive. Among those screened, seven women (0.1%) were found to have a high-grade squamous intraepithelial lesion. Of these, four underwent colposcopy-guided biopsy, while three were lost to follow-up; all four biopsies were negative for malignancy. Additionally, two women presented with apparent cervical growths. Regarding contraceptive practices, 2,690 women (43.3%) expressed support for using contraception, with the permanent method of sterilization being the most preferred by 1,990 women (74.13%). Conclusions Screening with basic investigations such as Pap smears and VIA plays a crucial role in identifying premalignant and malignant lesions at their earliest stages, enabling timely treatment to reduce morbidity and mortality. Additionally, most women opt for permanent contraception once they have completed their families.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.